Ginkgo Bioworks Holdings, Inc. (DNA)
After hours:
| Previous close | 0.8421 |
| Open | 0.8781 |
| Bid | 0.8500 x 3200 |
| Ask | 0.8599 x 1200 |
| Day's range | 0.8200 - 0.9100 |
| 52-week range | 0.7400 - 2.5450 |
| Volume | |
| Avg. volume | 29,376,614 |
| Market cap | 1.897B |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4600 |
| Earnings date | 01 Mar 2024 - 05 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.92 |
PR NewswireGinkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, beginning at 5:30 p.m. ET.
- PR Newswire
Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent directors at Ginkgo's upcoming annual meeting, scheduled to be held on June 13, 2024.
PR NewswireIl Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration. IGDI has identified a new sourdough bakery strain that can improve the flavor and aroma profile of baked goods via its starter culture product, Pater®. This collaboration will leverage Ginkgo's Adaptive Laboratory Evolution (ALE) technol
